Methadone Oxytocin Option

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Substance AbuseOpioid DependenceMethadone Treatment
Interventions
DRUG

Oxytocin

40 IU of the oxytocin will be administered intranasally for a one time dose at the beginning of the visit.

DRUG

Saline Nasal Spray

40 IU of the saline nasal spray will be administered once at the beginning of the visit.

Trial Locations (1)

94121

San Francisco VA Medical Center, San Francisco

All Listed Sponsors
collaborator

San Francisco Veterans Affairs Medical Center

FED

lead

University of California, San Francisco

OTHER

NCT01728909 - Methadone Oxytocin Option | Biotech Hunter | Biotech Hunter